Skip to main content
Log in

Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The release of endogenous dopamine evoked by electrical stimulation or by exposure to (+)-amphetamine (10 μM) was determined in superfused striatal slices of the rat.

The spontaneous and the electrically-evoked release of dopamine were significantly increased in the presence of nomifensine (10 μM). After reserpine pretreatment (5 mg/kg, s.c., 24 h), the striatal dopamine content was reduced by about 90%. Exposure to 10 μM (+)-amphetamine during 2 min released similar amounts of dopamine from striatal slices of untreated or reserpine pretreated rats. Similar results were obtained when monoamine oxidase activity was inhibited in vivo with pargyline.

Pretreatment with reserpine does not modify the (+)-amphetamine-induced release of dopamine, in spite of the marked reduction of the striatal dopamine content. These results provide direct evidence for the view that (+)-amphetamine releases dopamine from a special, reserpine-resistant pool of newly synthetized transmitter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arbilla S, Langer SZ (1980) Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum. Naunyn-Schmiedeberg's Arch Pharmacol 311:45–52

    Google Scholar 

  • Arbilla S, Dennis T, Langer SZ, Niddam R, Scatton B (1984a) Pretreatment with reserpine does not modify the amphetamine induced release of endogenous dopamine in striatal slices. Br J Pharmacol 82:249P

    Google Scholar 

  • Arbilla S, Baud P, Cantrill R, Langer SZ (1984b) Endogenous phenolamines: do they have a direct postsynaptic action on dopamine receptors in the central nervous system? Br J Pharmac 82:252P

  • Baud P, Arbilla S, Langer SZ (1984) Inhibition of the electricaly-evoked release of 3H-acetylcholine in rat striatal slices: an experimental model for drugs that enhance dopaminergic neurotransmission. J Neurochem (in press)

  • Boulton AA, Juorio AV (1982) Brain trace amines. In: Lajtha A (ed) Chemical and cellular architecture. Plenum Press, New York and London, pp 189–222

    Google Scholar 

  • Cantrill R, Arbilla S, Langer SZ (1983a) Inhibition by d-amphetamine of the electrically-evoked release of [3H]acetylcholine from slices of the rat striatum: involvement of dopamine receptors. Eur J Pharmacol 87:167–168

    Google Scholar 

  • Cantrill R, Arbilla S, Zivkovic B, Langer SZ (1983b) Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum: effects on 3H-acetylcholine release. Naunyn-Schmiedeberg's Arch Pharmacol 322:322–324

    Google Scholar 

  • Cubeddu LX, Hofmann IS (1983) Frequency-dependent release of acetylcholine and dopamine from rabbit striatum: its modulation by dopaminergic receptors. J Neurochem 41:94–101

    Google Scholar 

  • Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sciences 19:1161–1174

    Google Scholar 

  • Hertting G, Zumstein A, Jackisch R, Hoffmann I, Starke K (1980) Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 315:111–117

    Google Scholar 

  • Kamal L, Arbilla S, Langer SZ (1981) Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine. J Pharmac Exp Ther 216:592–598

    Google Scholar 

  • Kamal L, Arbilla S, Galzin AM, Langer SZ (1983) Amphetamine inhibits the electrically evoked release of 3H-dopamine from slices of the rabbit caudate. J Pharmac Exp Ther 227:446–458

    Google Scholar 

  • Langer SZ, Arbilla S (1984) The amphetamine paradox in dopaminergic neurotransmission. Trends Pharmacol Sci 5:387–390

    Google Scholar 

  • Lehmann J, Langer SZ (1983) The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience 10:1105–1120

    Google Scholar 

  • Lehmann J, Lee CR, Langer SZ (1983) Dopamine receptors modulating 3H-acetylcholine release in slices of the cat caudate: effects of (−)-N-(2-chloroethyl)-norapomorphine. Eur J Pharmacol 90:393–400

    Google Scholar 

  • Lowry OH, Rosebourgh NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Miller JC, Friedhoff AJ (1979) Effects of haloperidol and apomorphine on the K+-depolarized overflow of 3H-dopamine from striatal slices. Biochem Pharmacol 28:688–690

    Google Scholar 

  • Moore KE (1977) The actions of amphetamine on neurotransmitters: a brief review. Biological Psychiatry 12:451–462

    Google Scholar 

  • Scatton B (1982) Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptors multiplicity. J Pharmacol Exp Ther 220:197–202

    Google Scholar 

  • Semerdjian-Rouquier L, Bossi L, Scatton B (1981) Determination of 5-hydroxytryptophan, serotonin and 5-hydroxindoleacetic acid in rat and human brain and biological fluids by reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatography 218:663–670

    Google Scholar 

  • Starke K, Reimann W, Zumstein A, Hertting G (1978) Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 305:27–36

    Google Scholar 

  • Thornburg JE, Moore KE (1973) The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Neuropharmacol 12:853–866

    Google Scholar 

  • Uretsky NJ, Kamal L, Snodgrass SR (1979) Effect of divalent cations on the amphetamine-induced stimulation of [3H]-catechol synthesis in the striatum. J Neurochem 32:951–960

    Google Scholar 

  • Uretsky NJ, Snodgrass SR (1977) Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices. J Pharmacol Exp Ther 202:565–580

    Google Scholar 

  • Zumstein A, Karduck W, Starke K (1981) Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 316:205–217

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niddam, R., Arbilla, S., Scatton, B. et al. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine. Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 123–127 (1985). https://doi.org/10.1007/BF00501200

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00501200

Key words

Navigation